21-24 November 2024
29TH Annual meeting & Education Day of the Society for Neuro-Oncology Houston, Texas
The Society for Neuro-Oncology is a multidisciplinary organization dedicated to promoting advances in neuro-oncology through research and education.
Novocure presentations schedule
Friday, November 22
06:45 - 06:55 (America/Denver)
Oral Presentation
Phase 1 trial of personalized neoantigen vaccines in combination with standard care to treat glioblastoma
Chair(s): S. Cheng, S.J. Chen, C.C. Bozkus, A. Rubinstyn, J. Kodysh, T. O’Donnell, M. Saxena, G. Akturk, M. Meseck, R. Yong, B. Losic, J. Mandeli, R.S. Kim, S. Gnjatic, N. Bhardwaj, A. Hormigo
Saturday, November 23
10:50 - 10:55 (America/Denver)
Oral Presentation
Tumor Treating Fields (TTFields) therapy with chemoradiation, followed by maintenance TTFields therapy/temozolomide (TMZ), in newly diagnosed glioblastoma (ndGBM). Results of phase II clinical study.
Chair(s): R. Grossmann
Sunday, November 24
07:30 - 09:00 (America/Denver)
Oral Presentation
Newly designed Tumor Treating Fields (TTFields) arrays for the mouse head demonstrate efficacy for treatment of glioblastoma
Chair(s): S. Zbidat, R. Blatt, M. Sellevoll, M. Gabay, I. Schlachet, S. Cahal, S. Davidi, I. Tzchori, A. Haber, M. Giladi, Y. Palti
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
Outcomes of patients with isocitrate dehydrogenase-mutant WHO Grade 4 astrocytoma treated with Tumor Treating Fields (TTFields) therapy: a real-world analysis
Chair(s): J.M. Connelly, N. Avgeropoulos, P. Conlon, G. Chavez, O. Farber
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
Long-term survival and patterns of progression in patients with newly diagnosed glioblastoma treated with or without Tumor Treating Fields (TTFields) in a real-world setting
Chair(s): Riegel D, Bureau B, Conlon P, Chavez G, Connelly J
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
Delivery of TTFields to the infratentorial brain using HFE arrays
Chair(s): D Bhavanasi, O. Ze’evi, A. Naveh, D. Manzur, N. Shapira
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
Feasibility evaluation of Tumor Treating Fields (TTFields) therapy for brainstem gliomas
Chair(s): W. Shi, B. Berger, N. Urman
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
Tumour Treating Fields (TTFields) and DNA damage response (DDR) inhibitors enhance glioma cell death through chemo-/radiosensitisation
Chair(s): C.G. Jones, A. Vanderlinden, K.N. Myers, C. McGarrity-Cottrell, O. Rominiyi, S. Collis
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
The impact of Tumor Treating Fields on cancer stem-like cells isolated from the subventricular zone of glioblastoma patients
Chair(s): Y. Licón Muñoz, R.B. Sidebottom, S. Varela
Friday, November 22
06:30 - 08:30 (America/Denver)
Poster
Transmembrane water efflux rate (kio) is an MRI-detectable biomarker to evaluate the efficiency of TTFields treatment on glioblastoma
Chair(s): Songtao Hu, Yinhang Jia, Qingping He, Jiaqi Chu, Yongjie W, Ruiliang Bai